엘앤씨바이오
64,300KRWMarket close of 10/21 (Wed)
Up +1.58%+1,000KRWMarket close of 10/21 (Wed)
- Open
- 63,500
- High
- 67,500
- Low
- 63,200
- Day range
- Day range low 63,200 high 67,500, open 63,500, close 64,300, previous close 63,300
- Volume
- 31×10K shares
- 20.4B KRW 0.96× the 20-session average
Market close of 10/21 (Wed)
Where it sits in the 1-year range
26%1-year close range 45,700 to 118,300 won, 26% up from the low
26% of the way up from the lowest close in 1 year (252 sessions) · -45.6% from the high
Something to check
1 to check: foreign & institutional net outflow together
Free · no sign-inSource from 2021-05-17
Points to check
- Foreign & institutionalto check-27.8B KRW5 sessions: foreign -22.6B KRW · institutional -5.2B KRWLast 5 sessions: foreigners -22.6B KRW · institutions -5.2B KRW
- Daily moveusual range+1.58%+1.58%, 0.3× the usual (20-session average ±4.78%)That day +1.58% · usual ±4.78% · large-move threshold ±9.6%
- Trading valueusual range1.0×20.4B KRW, 1.0× the 20-session average0.96× the 20-session average · check threshold 3×
The other 3 are within the usual range
- EarningsOperating income, 8 quarters
- Recent filings0Last 14 days
- Data date10/21 (Wed)Market close
See the full check report
Same sector · 제약
Up +0.83%· 57 of 168 stocks up, preferred shares excluded · trading value 730.8B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 삼성바이오로직스 | Close over the last 20 sessions +1.5% | Up +1.87% | 166.1B KRW |
| 셀트리온 | Close over the last 20 sessions +9.6% | Up +0.10% | 119.2B KRW |
| 지투지바이오 | Close over the last 20 sessions +27.6% | Up +13.78% | 49.8B KRW |
| 삼익제약 | Close over the last 20 sessions -20.3% | Up +2.58% | 47.2B KRW |
| 유한양행 | Close over the last 20 sessions +11.7% | Up +0.46% | 35.3B KRW |
Schedule
- Q3 report due · 11/16 (Mon) · in 25 days
- Next data 10/23 (Fri) after 08:50
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.